unigene, spormann, dulberg, mayo

REVERSED

1700 Chemical & Materials Engineering
1726 Ex Parte Kato et al 11/727,472 SMITH 103(a) MCDERMOTT WILL & EMERY LLP EXAMINER RHEE, JANE J

1731 Ex Parte Uzunian et al 11/530,522 SMITH 102(b)/103(a) BASF CORPORATION EXAMINER ABU ALI, SHUANGYI

1763 Ex Parte Tabary et al 11/574,172 NAGUMO 103(a) ANTONELLI, TERRY, STOUT & KRAUS, LLP EXAMINER LI, AIQUN

1764 Ex Parte Callander et al 11/552,591 COLAIANNI 103(a) EDWIN A. SISSON , ATTORNEY AT LAW . LLC EXAMINER LEE, DORIS L

1788 Ex Parte Hayashi et al 11/572,522 COLAIANNI 112(1)/103(a) GREENBLUM & BERNSTEIN, P.L.C. EXAMINER DESAI, ANISH P

1789 Ex Parte Sarma et al 11/251,654 OWENS 102(b) 37 C.F.R. § 41.50(b) 103(a) JONES DAY EXAMINER YOO, HONG THI

2100 Computer Architecture and Software
2167 Ex Parte Factor et al 11/192,480 HUGHES 102(e) Stephen C. Kaufman IBM CORPORATION EXAMINER REYES, MARIELA D

2174 Ex Parte Williams et al 11/135,507 THOMAS 102(e)/103(a) HEWLETT-PACKARD COMPANY EXAMINER KUMAR, ANIL N

2800 Semiconductors, Electrical and Optical Systems and Components
2816 Ex Parte Kushnarenko 11/357,081 HUGHES 102(b)/103(a) EITAN MEHULAL LAW GROUP EXAMINER TRA, ANH QUAN

3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3634 Ex Parte Kinross 10/927,905 BAHR 103(a) HOWARD & HOWARD ATTORNEYS PLLC EXAMINER REDMAN, JERRY E

3700 Mechanical Engineering, Manufacturing, and Products & Design
3736 Ex Parte Fulton et al 10/839,112 MILLS 103(a) WELSH FLAXMAN & GITLER LLC EXAMINER SZMAL, BRIAN SCOTT
 
3762 Ex Parte Wallace et al 10/841,069 PRATS 102(b)/103(a) VISTA IP LAW GROUP LLP/BSC - NEUROMODULATION EXAMINER PATTON, AMANDA K

Thus, “[o]bviousness requires more than a mere showing that the prior art includes separate references covering each separate limitation in a claim under examination.” Unigene Laboratories, Inc. v. Apotex, Inc., 655 F.3d 1352, 1360 (Fed. Cir. 2011).

AFFIRMED-IN-PART

1600 Biotechnology and Organic Chemistry
1612 Ex Parte Liversidge et al 11/372,227 FRANKLIN 103(a) 103(a) Elan Drug Delivery, Inc. c/o Foley & Lardner EXAMINER MILLIGAN, ADAM C

1700 Chemical & Materials Engineering
1773 Ex Parte Daniel et al 11/537,679 COLAIANNI 103(a) 103(a) FAY SHARPE LLP / XEROX - PARC EXAMINER KWAK, DEAN P

Obviousness cannot be predicated on what is unknown. In re Spormann, 363 F.2d 444, 448 (CCPA 1966).

2100 Computer Architecture and Software
2166 Ex Parte Kaplan 11/129,275 THOMAS 103(a) 103(a) TUTUNJIAN & BITETTO, P.C. EXAMINER YEN, SYLING

2400 Networking, Mulitplexing, Cable, and Security
2432 Ex Parte Pinder et al 10/015,351 CHEN 103(a) 103(a) MERCHANT & GOULD SCIENTIFIC ATLANTA, A CISCO COMPANY EXAMINER NOBAHAR, ABDULHAKIM

3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3622 Ex Parte Wilson 11/931,384 CRAWFORD 103(a) 103(a) ROYLANCE, ABRAMS, BERDO & GOODMAN, L.L.P. EXAMINER SORKOWITZ, DANIEL M

3684 Ex Parte Celi et al 10/324,535 KIM 103(a) 103(a) Novak Druce + Quigg LLP EXAMINER FIELDS, BENJAMIN S

3689 Ex Parte Doyle et al 10/663,509 DESHPANDE 103(a) 102(b)/103(a)
CAREY, RODRIGUEZ, GREENBERG & O''KEEFE, LLP STEVEN M. GREENBERG EXAMINER MOONEYHAM, JANICE A
3695 Ex Parte Volchek et al 11/957,999 KIM 103(a) 103(a) 37 C.F.R. § 41.50(b) 103(a) WIGGIN AND DANA LLP EXAMINER MADAMBA, CLIFFORD B

See In re Dulberg, 289 F.2d 522, 523 (CCPA 1961) (making something separable is obvious). 

Dulberg, In re, 289 F.2d 522, 129 USPQ 348 (CCPA 1961) . . . . . . . . . . . . . . . . . . . . 2144.04

3700 Mechanical Engineering, Manufacturing, and Products & Design
3752 Ex Parte Daspit et al 09/569,178 HORNER 103(a) 103(a) TYCO FIRE PROTECTION PRODUCTS - WILLFIRE HC LLC EXAMINER HWU, DAVIS D

AFFIRMED

1600 Biotechnology and Organic Chemistry
1611 Ex Parte Jenkins et al 11/446,564 FRANKLIN 103(a)/nonstatutory obviousness-type double patenting Elan Drug Delivery, Inc. c/o Foley & Lardner EXAMINER BREDEFELD, RACHAEL EVA

1618 Ex Parte Van Bommel et al 10/596,920 ADAMS 103(a) 103(a) PHILIPS INTELLECTUAL PROPERTY & STANDARDS EXAMINER SCHLIENTZ, LEAH H

1636 Ex Parte O'BEIRNE et al 10/521,495 MILLS 102(b)/103(a) GE HEALTHCARE BIO-SCIENCES CORP. EXAMINER BOESEN, CHRISTIAN C

1700 Chemical & Materials Engineering
1733 Ex Parte Tanaka et al 11/666,830 LORIN 103(a) OBLON, SPIVAK, MCCLELLAND MAIER & NEUSTADT, L.L.P. EXAMINER YANG, JIE

1734 Ex Parte Bouet-Griffon et al 10/561,010 GAUDETTE 103(a) Baker Donelson Bearman Caldwell & Berkowitz PC EXAMINER LEE, REBECCA Y

1741 Ex Parte Liu et al 11/022,283 BEST 103(a) DORITY & MANNING, P.A. EXAMINER CORDRAY, DENNIS R

1745 Ex Parte Wargo et al 11/325,519 COLAIANNI 103(a) ROSENBERG, KLEIN & LEE EXAMINER CHAN, SING P

1765 Ex Parte Scurati et al 11/305,279 ADAMS 112(1) 103(a)
BRIDGESTONE AMERICAS, INC. EXAMINER ZEMEL, IRINA SOPJIA
1771 Ex Parte Bandali 11/635,324 COLAIANNI 103(a) LyondellBasell Industries EXAMINER SINGH, PREM C

1775 Ex Parte Ririe 10/478,453 SMITH 103(a) MAGINOT, MOORE & BECK, LLP EXAMINER BEISNER, WILLIAM H

1783 Ex Parte Cornelisse 11/068,705 COLAIANNI 103(a) DAY PITNEY LLP ACCOUNT: ILLINOIS TOOL WORKS INC. EXAMINER WATKINS III, WILLIAM P
 
2100 Computer Architecture and Software
2158 Ex Parte Thomas 11/363,239 HUGHES 103(a) SAP / FINNEGAN, HENDERSON LLP EXAMINER WU, YICUN

2177 Ex Parte Gebert et al 09/782,850 PER CURIAM Res Judicata/103(a) InfoPrint Solutions/ Blakely EXAMINER QUELER, ADAM M
 
2192 Ex Parte Shapiro 11/428,369 HAHN 103(a) LEMAIRE PATENT LAW FIRM, P.L.L.C. EXAMINER DAO, THUY CHAN
 
2400 Networking, Mulitplexing, Cable, and Security
2454 Ex Parte Hong et al 10/139,301 KUMAR 103(a) THE FARRELL LAW FIRM, P.C. EXAMINER NGUYEN, DUSTIN

2600 Communications
2617 Ex Parte Golestani et al 10/953,356 SMITH 103(a) CAPITOL PATENT & TRADEMARK LAW FIRM, PLLC EXAMINER EDOUARD, PATRICK NESTOR

In the event of further prosecution, the Examiner should evaluate claim 1 in light of the recent decision from the U.S. Supreme Court in Mayo Collaborative Servs. v. Prometheus Labs., Inc., 132 S.Ct. 1289 (2012), to determine whether claim 1 recites anything more than the combination of a law of nature with a known step of allocating. 

2625 Ex Parte Sievert et al 10/909,237 RUGGIERO 103(a) HEWLETT-PACKARD COMPANY EXAMINER DICKER, DENNIS T
 
2800 Semiconductors, Electrical and Optical Systems and Components
2833 Ex Parte Denneler et al 10/416,071 MacDONALD 103(a) KENYON & KENYON LLP EXAMINER HAMMOND, BRIGGITTE R
 
2835 Ex Parte Neal et al 11/584,126 HUGHES 102(b)/102(e)/103(a) HEWLETT-PACKARD COMPANY EXAMINER PAPE, ZACHARY

2857 Ex Parte Randall 11/174,118 DIXON 103(a) MAGINOT, MOORE & BECK, LLP EXAMINER BUI, BRYAN

2871 Ex Parte Vesely et al 10/098,681 DILLON 103(a) DICKSTEIN SHAPIRO MORIN & OSHINSKY LLP EXAMINER CHUNG, DAVID Y

3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3695 Ex Parte Doyle et al 11/303,606 CRAWFORD 102(b) IM IP Law PLLC EXAMINER OYEBISI, OJO O

3700 Mechanical Engineering, Manufacturing, and Products & Design
3731 Ex Parte Martinek 10/972,464 SCHEINER 103(a) Tyco Healthcare Group LP d/b/a Covidien EXAMINER SONNETT, KATHLEEN C

3735 Ex Parte Shah et al 10/861,837 FRANKLIN 103(a) Gates & Cooper LLP EXAMINER TOTH, KAREN E

3738 Ex Parte Hazebrouck et al 11/860,833 BONILLA 102(b)/103(a) BARNES & THORNBURG LLP EXAMINER HOBAN, MELISSA A

3900 Central Reexamination Unit (CRU)
3625 Ex Parte 7,379,900 et al Ex parte Variant Holdings, LLC and Variant, Inc., Appellants and Patent Owners 90/010,701 09/504,374 TURNER 102(b)/102(e) STEPHEN WREN EXAMINER CHOI, WOO H original EXAMINER ZURITA, JAMES H

REHEARING

DENIED

1600 Biotechnology and Organic Chemistry
1612 Ex Parte Levine et al 11/510,094 WALSH 103(a) ABELMAN, FRAYNE & SCHWAB EXAMINER KISHORE, GOLLAMUDI S